Protagonist Therapeutics Inc
(PTGX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -47,264 | -39,501 | -20,080 | -77,187 | -59,686 |
| Depreciation Amortization | 1,799 | 1,085 | 542 | 1,930 | 1,451 |
| Income taxes - deferred | 1,404 | 1,412 | 183 | -775 | -1,548 |
| Accounts receivable | 3,966 | 3,758 | 3,161 | -2,168 | 2,642 |
| Accounts payable and accrued liabilities | 847 | -186 | 767 | -2,799 | -4,206 |
| Other Working Capital | -16,073 | -4,955 | 910 | 26,144 | 26,352 |
| Other Operating Activity | 1,704 | 1,057 | -1,331 | 13,328 | 7,757 |
| Operating Cash Flow | $-53,617 | $-37,330 | $-15,848 | $-41,527 | $-27,238 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -346 | -271 | -138 | -967 | -749 |
| Purchase Of Investment | -147,600 | -66,753 | -20,883 | -166,936 | -117,807 |
| Sale Of Investment | 131,383 | 104,583 | 63,751 | 114,193 | 77,400 |
| Investing Cash Flow | $-16,563 | $37,559 | $42,730 | $-53,710 | $-41,156 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 9,765 | N/A |
| Debt Repayment | -10,524 | -10,524 | N/A | N/A | N/A |
| Common Stock Issued | 131,183 | 123,514 | 406 | 36,271 | 36,257 |
| Other Financing Activity | -14 | -14 | -7 | 0 | 0 |
| Financing Cash Flow | $120,645 | $112,976 | $399 | $46,036 | $36,257 |
| Exchange Rate Effect | 154 | 31 | -72 | -26 | 99 |
| Beginning Cash Position | 33,466 | 33,466 | 33,466 | 82,693 | 82,693 |
| End Cash Position | 84,085 | 146,702 | 60,675 | 33,466 | 50,655 |
| Net Cash Flow | $50,619 | $113,236 | $27,209 | $-49,227 | $-32,038 |
| Free Cash Flow | |||||
| Operating Cash Flow | -53,617 | -37,330 | -15,848 | -41,527 | -27,238 |
| Capital Expenditure | -346 | -271 | -138 | -967 | -749 |
| Free Cash Flow | -53,963 | -37,601 | -15,986 | -42,494 | -27,987 |